Metabolic Disorders in Patients with HIV

Human Immunodeficiency Virus (HIV) infection and subsequent antiretroviral therapy (ART) are known to be related to different metabolic disorders. Although ART decreased HIV-associated mortality and morbidity, mortality rates in patients with HIV and ART are 3 to 15 higher than those in the general...

Full description

Bibliographic Details
Main Authors: Radu Florentina, Jipa Raluca Elena, Rusu Emilia, Cursaru Raluca, Drăguţ Ramona, Stegaru Daniela, Gheorghiţă Andra Gabriela, Radulian Gabriela
Format: Article
Language:English
Published: Sciendo 2016-12-01
Series:Romanian Journal of Diabetes Nutrition and Metabolic Diseases
Subjects:
Online Access:http://www.degruyter.com/view/j/rjdnmd.2016.23.issue-4/rjdnmd-2016-0046/rjdnmd-2016-0046.xml?format=INT
Description
Summary:Human Immunodeficiency Virus (HIV) infection and subsequent antiretroviral therapy (ART) are known to be related to different metabolic disorders. Although ART decreased HIV-associated mortality and morbidity, mortality rates in patients with HIV and ART are 3 to 15 higher than those in the general population. More than 50% of the mortality is due to diseases like: diabetes mellitus (DM), hypertension, cardiovascular diseases (CVD), chronic renal disease and complications following bone fractures. In patients with HIV the metabolic disorders are mainly caused by mithocondrial toxicity, a side effect of ART, and they are represented by: dyslipidemia, lipoatrophy, insulin resistance and diabetes mellitus.
ISSN:2284-6417